BMY logo

Bristol-Myers Squibb (BMY) CAPEX

annual CAPEX:

$1.25B+$39.00M(+3.23%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BMY annual capital expenditures is $1.25 billion, with the most recent change of +$39.00 million (+3.23%) on December 1, 2024.
  • During the last 3 years, BMY annual CAPEX has risen by +$275.00 million (+28.26%).
  • BMY annual CAPEX is now at all-time high.

Performance

BMY CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

quarterly CAPEX:

$378.00M+$54.00M(+16.67%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BMY quarterly capital expenditures is $378.00 million, with the most recent change of +$54.00 million (+16.67%) on December 1, 2024.
  • Over the past year, BMY quarterly CAPEX has increased by +$48.00 million (+14.55%).
  • BMY quarterly CAPEX is now -19.23% below its all-time high of $468.00 million, reached on December 31, 2002.

Performance

BMY quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

TTM CAPEX:

$1.25B+$48.00M(+4.00%)
December 1, 2024

Summary

  • As of today (April 18, 2025), BMY TTM capital expenditures is $1.25 billion, with the most recent change of +$48.00 million (+4.00%) on December 1, 2024.
  • Over the past year, BMY TTM CAPEX has increased by +$39.00 million (+3.23%).
  • BMY TTM CAPEX is now -1.27% below its all-time high of $1.26 billion, reached on March 31, 2017.

Performance

BMY TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

BMY CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.2%+14.6%+3.2%
3 y3 years+28.3%+14.6%+3.2%
5 y5 years+49.3%+14.6%+3.2%

BMY CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+28.3%at high+53.0%at high+18.5%
5 y5-yearat high+65.7%at high+188.6%at high+73.1%
alltimeall timeat high+240.1%-19.2%+410.8%-1.3%+985.2%

Bristol-Myers Squibb CAPEX History

DateAnnualQuarterlyTTM
Dec 2024
$1.25B(+3.2%)
$378.00M(+16.7%)
$1.25B(+4.0%)
Sep 2024
-
$324.00M(+23.7%)
$1.20B(-1.5%)
Jun 2024
-
$262.00M(-7.7%)
$1.22B(+0.2%)
Mar 2024
-
$284.00M(-13.9%)
$1.22B(+0.5%)
Dec 2023
$1.21B(+8.1%)
$330.00M(-3.5%)
$1.21B(-1.3%)
Sep 2023
-
$342.00M(+32.0%)
$1.23B(+8.4%)
Jun 2023
-
$259.00M(-6.8%)
$1.13B(-1.1%)
Mar 2023
-
$278.00M(-19.7%)
$1.14B(+2.2%)
Dec 2022
$1.12B(+14.9%)
$346.00M(+40.1%)
$1.12B(+2.4%)
Sep 2022
-
$247.00M(-9.2%)
$1.09B(-2.1%)
Jun 2022
-
$272.00M(+7.5%)
$1.11B(+5.9%)
Mar 2022
-
$253.00M(-20.9%)
$1.05B(+8.2%)
Dec 2021
$973.00M(+29.2%)
$320.00M(+18.5%)
$973.00M(+4.0%)
Sep 2021
-
$270.00M(+28.6%)
$936.00M(+14.3%)
Jun 2021
-
$210.00M(+21.4%)
$819.00M(+10.7%)
Mar 2021
-
$173.00M(-38.9%)
$740.00M(-1.7%)
Dec 2020
$753.00M(-9.9%)
$283.00M(+85.0%)
$753.00M(+4.4%)
Sep 2020
-
$153.00M(+16.8%)
$721.00M(-4.9%)
Jun 2020
-
$131.00M(-29.6%)
$758.00M(-7.3%)
Mar 2020
-
$186.00M(-25.9%)
$818.00M(-2.2%)
Dec 2019
$836.00M(-12.1%)
$251.00M(+32.1%)
$836.00M(-4.5%)
Sep 2019
-
$190.00M(-0.5%)
$875.00M(-3.7%)
Jun 2019
-
$191.00M(-6.4%)
$909.00M(-0.8%)
Mar 2019
-
$204.00M(-29.7%)
$916.00M(-3.7%)
Dec 2018
$951.00M(-9.9%)
$290.00M(+29.5%)
$951.00M(+3.9%)
Sep 2018
-
$224.00M(+13.1%)
$915.00M(-4.0%)
Jun 2018
-
$198.00M(-17.2%)
$953.00M(-5.0%)
Mar 2018
-
$239.00M(-5.9%)
$1.00B(-4.9%)
Dec 2017
$1.05B(-13.2%)
$254.00M(-3.1%)
$1.05B(-10.0%)
Sep 2017
-
$262.00M(+5.6%)
$1.17B(-6.3%)
Jun 2017
-
$248.00M(-14.8%)
$1.25B(-1.0%)
Mar 2017
-
$291.00M(-21.6%)
$1.26B(+4.0%)
Dec 2016
$1.22B(+48.2%)
$371.00M(+8.8%)
$1.22B(+7.6%)
Sep 2016
-
$341.00M(+30.7%)
$1.13B(+10.5%)
Jun 2016
-
$261.00M(+7.9%)
$1.02B(+10.4%)
Mar 2016
-
$242.00M(-15.1%)
$926.00M(+12.9%)
Dec 2015
$820.00M(+55.9%)
$285.00M(+21.8%)
$820.00M(+12.9%)
Sep 2015
-
$234.00M(+41.8%)
$726.00M(+21.2%)
Jun 2015
-
$165.00M(+21.3%)
$599.00M(+10.1%)
Mar 2015
-
$136.00M(-28.8%)
$544.00M(+3.4%)
Dec 2014
$526.00M(-2.0%)
$191.00M(+78.5%)
$526.00M(-1.7%)
Sep 2014
-
$107.00M(-2.7%)
$535.00M(-3.1%)
Jun 2014
-
$110.00M(-6.8%)
$552.00M(+2.2%)
Mar 2014
-
$118.00M(-41.0%)
$540.00M(+0.6%)
Dec 2013
$537.00M(-2.0%)
$200.00M(+61.3%)
$537.00M(+4.9%)
Sep 2013
-
$124.00M(+26.5%)
$512.00M(-2.5%)
Jun 2013
-
$98.00M(-14.8%)
$525.00M(-2.8%)
Mar 2013
-
$115.00M(-34.3%)
$540.00M(-1.5%)
Dec 2012
$548.00M(+49.3%)
$175.00M(+27.7%)
$548.00M(+8.1%)
Sep 2012
-
$137.00M(+21.2%)
$507.00M(+11.7%)
Jun 2012
-
$113.00M(-8.1%)
$454.00M(+9.4%)
Mar 2012
-
$123.00M(-8.2%)
$415.00M(+13.1%)
Dec 2011
$367.00M(-13.4%)
$134.00M(+59.5%)
$367.00M(+2.5%)
Sep 2011
-
$84.00M(+13.5%)
$358.00M(-1.4%)
Jun 2011
-
$74.00M(-1.3%)
$363.00M(-1.9%)
Mar 2011
-
$75.00M(-40.0%)
$370.00M(-12.7%)
Dec 2010
$424.00M(-41.9%)
$125.00M(+40.4%)
$424.00M(-14.3%)
Sep 2010
-
$89.00M(+9.9%)
$495.00M(-13.9%)
Jun 2010
-
$81.00M(-37.2%)
$575.00M(-12.6%)
Mar 2010
-
$129.00M(-34.2%)
$658.00M(-9.9%)
Dec 2009
$730.00M(-22.4%)
$196.00M(+16.0%)
$730.00M(-10.9%)
Sep 2009
-
$169.00M(+3.0%)
$819.00M(-3.2%)
Jun 2009
-
$164.00M(-18.4%)
$846.00M(-5.2%)
Mar 2009
-
$201.00M(-29.5%)
$892.00M(-5.2%)
Dec 2008
$941.00M(+11.6%)
$285.00M(+45.4%)
$941.00M(+3.9%)
Sep 2008
-
$196.00M(-6.7%)
$906.00M(+1.2%)
Jun 2008
-
$210.00M(-16.0%)
$895.00M(+0.4%)
Mar 2008
-
$250.00M(0.0%)
$891.00M(+5.7%)
Dec 2007
$843.00M
$250.00M(+35.1%)
$843.00M(+2.9%)
Sep 2007
-
$185.00M(-10.2%)
$819.00M(-1.8%)
DateAnnualQuarterlyTTM
Jun 2007
-
$206.00M(+2.0%)
$834.00M(+5.2%)
Mar 2007
-
$202.00M(-10.6%)
$793.00M(0.0%)
Dec 2006
$793.00M(+3.3%)
$226.00M(+13.0%)
$793.00M(+3.0%)
Sep 2006
-
$200.00M(+21.2%)
$770.00M(+1.9%)
Jun 2006
-
$165.00M(-18.3%)
$756.00M(-4.2%)
Mar 2006
-
$202.00M(-0.5%)
$789.00M(+2.7%)
Dec 2005
$768.00M(-5.1%)
$203.00M(+9.1%)
$768.00M(0.0%)
Sep 2005
-
$186.00M(-6.1%)
$768.00M(-13.2%)
Jun 2005
-
$198.00M(+9.4%)
$885.00M(+7.0%)
Mar 2005
-
$181.00M(-10.8%)
$827.00M(+2.2%)
Dec 2004
$809.00M(-18.3%)
$203.00M(-33.0%)
$809.00M(-13.5%)
Sep 2004
-
$303.00M(+116.4%)
$935.00M(+6.4%)
Jun 2004
-
$140.00M(-14.1%)
$879.00M(-6.5%)
Mar 2004
-
$163.00M(-50.5%)
$940.00M(-5.1%)
Dec 2003
$990.00M(-16.2%)
$329.00M(+33.2%)
$990.00M(-12.3%)
Sep 2003
-
$247.00M(+22.9%)
$1.13B(+0.9%)
Jun 2003
-
$201.00M(-5.6%)
$1.12B(-5.5%)
Mar 2003
-
$213.00M(-54.5%)
$1.18B(+0.2%)
Dec 2002
$1.18B(+15.5%)
$468.00M(+97.5%)
$1.18B(+12.6%)
Sep 2002
-
$237.00M(-10.9%)
$1.05B(-3.6%)
Jun 2002
-
$266.00M(+26.1%)
$1.09B(+2.8%)
Mar 2002
-
$211.00M(-37.2%)
$1.06B(+3.5%)
Dec 2001
$1.02B(+73.7%)
$336.00M(+21.7%)
$1.02B(+8.3%)
Sep 2001
-
$276.00M(+16.9%)
$945.00M(+17.0%)
Jun 2001
-
$236.00M(+34.9%)
$808.00M(+20.1%)
Mar 2001
-
$175.00M(-32.2%)
$673.00M(+14.3%)
Dec 2000
$589.00M(-16.9%)
$258.00M(+85.6%)
$589.00M(+0.7%)
Sep 2000
-
$139.00M(+37.6%)
$585.00M(-2.8%)
Jun 2000
-
$101.00M(+11.0%)
$602.00M(-11.2%)
Mar 2000
-
$91.00M(-64.2%)
$678.00M(-4.4%)
Dec 1999
$709.00M(-10.0%)
$254.00M(+62.8%)
$709.00M(+0.4%)
Sep 1999
-
$156.00M(-11.9%)
$706.00M(-2.2%)
Jun 1999
-
$177.00M(+45.1%)
$722.00M(-4.5%)
Mar 1999
-
$122.00M(-51.4%)
$756.00M(-4.1%)
Dec 1998
$788.00M(+2.7%)
$251.00M(+45.9%)
$788.00M(-9.0%)
Sep 1998
-
$172.00M(-18.5%)
$866.00M(+0.3%)
Jun 1998
-
$211.00M(+37.0%)
$863.00M(+7.9%)
Mar 1998
-
$154.00M(-53.2%)
$800.00M(+4.3%)
Dec 1997
$767.00M(+27.6%)
$329.00M(+94.7%)
$767.00M(+17.8%)
Sep 1997
-
$169.00M(+14.2%)
$651.00M(+5.0%)
Jun 1997
-
$148.00M(+22.3%)
$620.00M(+2.1%)
Mar 1997
-
$121.00M(-43.2%)
$607.00M(+1.0%)
Dec 1996
$601.00M(+17.2%)
$213.00M(+54.3%)
$601.00M(+5.6%)
Sep 1996
-
$138.00M(+2.2%)
$569.00M(+2.9%)
Jun 1996
-
$135.00M(+17.4%)
$553.00M(+2.8%)
Mar 1996
-
$115.00M(-36.5%)
$538.00M(+4.9%)
Dec 1995
$513.00M(-10.5%)
$181.00M(+48.4%)
$513.00M(-2.1%)
Sep 1995
-
$122.00M(+1.7%)
$524.00M(-3.7%)
Jun 1995
-
$120.00M(+33.3%)
$544.00M(-2.2%)
Mar 1995
-
$90.00M(-53.1%)
$556.00M(-3.0%)
Dec 1994
$573.00M(+0.5%)
$192.00M(+35.2%)
$573.00M(-3.5%)
Sep 1994
-
$142.00M(+7.6%)
$594.00M(+2.2%)
Jun 1994
-
$132.00M(+23.4%)
$581.00M(+1.6%)
Mar 1994
-
$107.00M(-49.8%)
$572.00M(+0.4%)
Dec 1993
$570.00M(-11.9%)
$213.00M(+65.1%)
$570.00M(+5.0%)
Sep 1993
-
$129.00M(+4.9%)
$543.00M(-5.7%)
Jun 1993
-
$123.00M(+17.1%)
$576.00M(-8.6%)
Mar 1993
-
$105.00M(-43.5%)
$630.00M(-2.6%)
Dec 1992
$647.00M(+3.0%)
$186.00M(+14.8%)
$647.00M(-6.5%)
Sep 1992
-
$162.00M(-8.5%)
$692.00M(+2.8%)
Jun 1992
-
$177.00M(+45.1%)
$673.00M(+4.7%)
Mar 1992
-
$122.00M(-47.2%)
$643.00M(+2.4%)
Dec 1991
$628.00M(+22.4%)
$231.00M(+61.5%)
$628.00M(+11.3%)
Sep 1991
-
$143.00M(-2.7%)
$564.00M(+6.8%)
Jun 1991
-
$147.00M(+37.4%)
$528.00M(+4.6%)
Mar 1991
-
$107.00M(-35.9%)
$505.00M(-1.6%)
Dec 1990
$513.00M(-7.6%)
$167.00M(+56.1%)
$513.00M(+48.3%)
Sep 1990
-
$107.00M(-13.7%)
$346.00M(+44.8%)
Jun 1990
-
$124.00M(+7.8%)
$239.00M(+107.8%)
Mar 1990
-
$115.00M
$115.00M
Dec 1989
$555.00M
-
-

FAQ

  • What is Bristol-Myers Squibb annual capital expenditures?
  • What is the all time high annual CAPEX for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual CAPEX year-on-year change?
  • What is Bristol-Myers Squibb quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?
  • What is Bristol-Myers Squibb TTM capital expenditures?
  • What is the all time high TTM CAPEX for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM CAPEX year-on-year change?

What is Bristol-Myers Squibb annual capital expenditures?

The current annual CAPEX of BMY is $1.25B

What is the all time high annual CAPEX for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual capital expenditures is $1.25B

What is Bristol-Myers Squibb annual CAPEX year-on-year change?

Over the past year, BMY annual capital expenditures has changed by +$39.00M (+3.23%)

What is Bristol-Myers Squibb quarterly capital expenditures?

The current quarterly CAPEX of BMY is $378.00M

What is the all time high quarterly CAPEX for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly capital expenditures is $468.00M

What is Bristol-Myers Squibb quarterly CAPEX year-on-year change?

Over the past year, BMY quarterly capital expenditures has changed by +$48.00M (+14.55%)

What is Bristol-Myers Squibb TTM capital expenditures?

The current TTM CAPEX of BMY is $1.25B

What is the all time high TTM CAPEX for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM capital expenditures is $1.26B

What is Bristol-Myers Squibb TTM CAPEX year-on-year change?

Over the past year, BMY TTM capital expenditures has changed by +$39.00M (+3.23%)
On this page